Metabolomic profiling of autoimmune hepatitis: The diagnostic utility of nuclear magnetic resonance spectroscopy

Journal of Proteome Research

Volumn 13, Issue 8, 2014, Pages 3792-3801

  Wang, Jia Bo ^a   Pu, Shi Biao ^a,b   Sun, Ying ^a   Li, Zhong Feng ^c   Niu, Ming ^a   Yan, Xian Zhong ^d   Zhao, Yan Ling ^a   Wang, Li Feng ^a   Qin, Xue Mei ^e   Ma, Zhi Jie ^f   Zhang, Ya Ming ^a   Li, Bao Sen ^a   Luo, Sheng Qiang ^a   Gong, Man ^a   Sun, Yong Qiang ^a   Zou, Zheng Sheng ^a   Xiao, Xiao He ^a  

^a 302 MILITARY HOSPITAL   (China)

^b YUNNAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c CAPITAL NORMAL UNIVERSITY   (China)

^d BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^e SHANXI UNIVERSITY   (China)

^f CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Autoimmune hepatitis; biomarker; diagnosis; metabolomics; NMR

Indexed keywords

ACETIC ACID; ACETOACETIC ACID; ACETONE; AROMATIC AMINO ACID; BIOLOGICAL MARKER; BRANCHED CHAIN AMINO ACID; CITRIC ACID; CREATININE; DIMETHYLAMINE; GLUCOSE; GLUTAMINE; HISTIDINE; LACTIC ACID; PYRUVIC ACID;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENERGY METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LACTATE BLOOD LEVEL; MALE; METABOLOMICS; MOLECULAR DIAGNOSIS; NUCLEAR MAGNETIC RESONANCE SPECTROMETER; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TOXIC HEPATITIS;

EID: 84905401826     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500462f     Document Type: Article

References (40)

1. Edward, L.; Krawitt, M. D. Autoimmune hepatitis N. Engl. J. Med. 2006, 354, 54-66
2. Alvarez, F.; Berg, P. A.; Bianchi, F. B.; Bianchi, L.; Burroughs, A. K.; Cancado, E. L. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis J. Hepatol. 1999, 31, 929-938
3. Czaja, A. J. Challenges in the diagnosis and management of autoimmune hepatitis Can. J. Gastroenterol. 2013, 27, 531-539
4. Zachou, K.; Muratori, P.; Koukoulis, G. K.; Granito, A.; Gatselis, N.; Fabbri, A. Autoimmune hepatitis-current management and challenges Aliment. Pharmacol. Ther. 2013, 38, 887-913
5. Manns, M. P.; Czaja, A. J.; Gorham, J. D.; Krawitt, E. L.; Mieli-Vergani, G.; Vergani, D.; Vierling, J. M. Diagnosis and management of autoimmune hepatitis Hepatology 2010, 51, 2193-2213
6. Manns, M. P.; Strassburg, C. P. Autoimmune hepatitis: clinical challenges Gastroenterology 2001, 120, 1502-1517
7. Boberg, K. M.; Fausa, O.; Haaland, T.; Holter, E.; Mellbye, O. J.; Spurkland, A.; Schrumpf, E. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis Hepatology 1996, 23, 1369-1376
8. Beyoglu, D.; Idle, J. R. The metabolomic window into hepatobiliary disease J. Hepatol. 2013, 59, 842-858
9. Saude, E. J.; Skappak, C. D.; Regush, S.; Cook, K.; Ben-Zvi, A.; Becker, A.; Moqbel, R.; Sykes, B. D.; Rowe, B. H.; Adamko, D. J. Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy J. Allergy Clin. Immunol. 2011, 127, 757-764
10. Reisdorph, N.; Wechsler, M. E. Utilizing metabolomics to distinguish asthma phenotypes: strategies and clinical implications Allergy 2013, 68, 959-962
11. Mehrpour, M.; Kyani, A.; Tafazzoli, M.; Fathi, F.; Joghataie, M. T. A metabonomics investigation of multiple sclerosis by nuclear magnetic resonance Magn. Reson. Chem. 2013, 51, 102-109
12. Trottier, J.; Biaek, A.; Caron, P.; Straka, R. J.; Heathcote, J.; Milkiewicz, P.; Barbier, O. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study Dig. Liver Dis. 2012, 44, 303-310
13. Broadhurst, D. I.; Kell, D. B. Statistical strategies for avoiding false discoveries in metabolomics and related experimengts Metabolomics 2006, 2, 171-196
14. van den Berg, R. A.; Hoefsloot, H. C.; Westerhuis, J. A.; Smilde, A. K.; van der Werf, M. J. Centering, scaling, and transformations: improving the biological information content of metabolomics data BMC Genomics 2006, 8, 142
15. Chang, D.; Weljie, A.; Newton, J. Leveraging latent information in NMR spectra for robust predictive models Pac. Symp. Biocomput. 2007, 115-126
16. Brindle, J. T.; Antti, H.; Holmes, E.; Tranter, G.; Nicholson, J. K.; Bethell, H. W.; Clarke, S.; Schofield, P. M.; McKilligin, E.; Mosedale, D. E.; Grainger, D. J. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics Nat. Med. 2002, 8, 1439-1444
17. Czaja, A. J. The management of autoimmune hepatitis beyond consensus guidelines Aliment. Pharmacol. Ther. 2013, 38, 343-364
18. Jones, R. G.; Thompson, C. B. Revving the engine: signal transduction fuels T cell activation Immunity 2007, 27, 173-178
19. Vander Heiden, M. G.; Cantley, L. C.; Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 2009, 324, 1029-1033
20. Gatza, E.; Wahl, D. R.; Opipari, A. W.; Sundberg, T. B.; Reddy, P.; Liu, C.; Glick, G. D.; Ferrara, J. L. M. Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease Sci. Transl. Med. 2011, 3, 67ra8
21. MacIver, N. J.; Jacobs, S. R.; Wieman, H. L.; Wofford, J. A.; Coloff, J. L.; Rathmell, J. C. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival J. Leukocyte Biol. 2008, 84, 949-957
22. Wen, H.; Yoo, S. S.; Kang, J.; Kim, H. G.; Park, J.-S.; Jeong, S.; Lee, J. I.; Kwon, H. N.; Kang, S.; Lee, D.-H.; Park, S. A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer J. Hepatol. 2010, 52, 228-233
23. Lardy, H. A.; Paetkau, V.; Walter, P. Paths of carbon in gluconeogenesis and lipogenesis: the role of mitochondria in supplying precursors of phosphoenolpyruvate Proc. Natl. Acad. Sci. U.S.A. 1965, 53, 1410-1415
24. Munshi, S. U.; Taneja, S.; Bhavesh, N. S.; Shastri, J.; Aggarwal, R.; Jameel, S. Metabonomic analysis of hepatitis E patients shows deregulated metabolic cycles and abnormalities in amino acid metabolism J. Viral Hepatitis 2011, 18, e591-e602
25. Yu, K.; Sheng, G.; Sheng, J.; Chen, Y.; Xu, W.; Liu, X.; Cao, H.; Qu, H.; Cheng, Y.; Li, L. A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus J. Proteome Res. 2007, 6, 2413-2419
26. Kalhan, S. C.; Guo, L.; Edmison, J.; Dasarathy, S.; McCullough, A. J.; Hanson, R. W. Plasma metabolomic profile in non-alcoholic fatty liver disease Metabolism 2011, 60, 404-413
27. Toye, A. A.; Dumas, M. E.; Blancher, C.; Rothwell, A. R.; Fearnside, J. F.; Wilder, S. P. Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice Diabetologia 2007, 50, 1867-1879
28. Puri, P.; Wiest, M. M.; Cheung, O.; Mirshahi, F.; Sargeant, C.; Min, H. K. The plasma lipidomic signature of non-alcoholic steatohepatitis Hepatology 2009, 50, 1827-1838
29. Garcia-Canaveras, J. C.; Donato, M. T.; Castell, J. V.; Lahoz, A. A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations J. Proteome Res. 2011, 10, 4825-4834
30. Czaja, A. J. Cholestatic phenotypes of autoimmune hepatitis. Clin. Gastroenterol. Hepatol. [Online early access.] DOI: 10.1016/j.cgh.2013.08.039. Published Online: Sept 9, 2013.
31. Chazouilleres, O.; Wendum, D.; Serfaty, L. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy Hepatology 1998, 28, 296-301
32. Wang, X.; Zhang, A.; Han, Y.; Wang, P.; Sun, H.; Song, G.; Dong, T.; Yuan, Y.; Yuan, X.; Zhang, M.; Xie, N.; Zhang, H.; Dong, H.; Dong, W. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease Mol. Cell. Proteomics 2012, 11, 370-380
33. Fitch, C. D.; Sinton, D. W. A study of creatine metabolism in diseases causing muscle wasting J. Clin. Invest. 1964, 43, 444-452
34. Hounoki, H.; Shinoda, K.; Ogawa, R.; Taki, H.; Tsuneyama, K.; Tobe, K. Simultaneously developed polymyositis and autoimmune hepatitis BMJ Case Rep. 2011, 8, bcr0920114763
35. Kurihara, Y.; Shishido, T.; Oku, K.; Takamatsu, M.; Ishiguro, H.; Suzuki, A.; Sekita, T.; Shinagawa, T.; Ishihara, T.; Nakashima, R.; Fujii, T.; Okano, Y. Polymyositis associated with autoimmune hepatitis, primary biliary cirrhosis, and autoimmunethrombocytopenic purpura Mod. Rheumatol. 2011, 21, 325-329
36. 1H NMR based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis Cancer Sci. 2009, 100, 782-785
37. Tessari, P.; Vettore, M.; Millioni, R.; Puricelli, L.; Orlando, R. Effect of liver cirrhosis on phenylalanine and tyrosine metabolism Curr. Opin. Clin. Nutr. Metab. Care 2010, 13, 81-86
38. Tajiri, K.; Shimizu, Y. Branched-chain amino acids in liver diseases World J. Gastroenterol. 2013, 19, 7620-7629
39. Kessler, W. R.; Cummings, O. W.; Eckert, G.; Chalasani, N.; Lumeng, L.; Kwo, P. Y. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis Clin. Gastroenterol. Hepatol. 2004, 2, 625-631
40. Feld, J. J.; Dinh, H.; Arenovich, T.; Marcus, V. A.; Wanless, I. R.; Heathcote, E. J. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome Hepatology 2005, 42, 53-62